ESR1 and breast cancer: Taken together, these data indicate that the efficiency of NHEJ, but not of HR, is negatively affected by anti-estrogen therapy in ER+ models of breast cancer and may be contributing to the radiosensitization phenotype observed with concurrent administration of anti-estrogen therapy and RT.